Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07485166 · ClinicalTrials.gov registry record
Emulation of the CheckMate 017/057 (NCT01642004 and NCT01673867) Trials Using Specialty Oncology Electronic Health Records Databases
A clinical trial of Advanced Non-squamous Non-small-cell Lung Cancer and Advanced Non-Small Cell Squamous Lung Cancer, sponsored by Brigham and Women's Hospital.
- Active
- Registry status
- 810
- Enrollment target
- 1
- Study location
NCT07485166 is a study of Advanced Non-squamous Non-small-cell Lung Cancer and Advanced Non-Small Cell Squamous Lung Cancer that is active but no longer recruiting, run by Brigham and Women's Hospital. The registered enrollment target is 810 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07485166, a study of Advanced Non-squamous Non-small-cell Lung Cancer and Advanced Non-Small Cell Squamous Lung Cancer, is active but no longer recruiting, sponsored by Brigham and Women's Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- 810 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigators are building an empirical evidence base for real world data through large-scale emulation of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how to implement such studies.
Conditions Studied
Interventions
- DRUG Initiation of nivolumab
- DRUG Initiation of docetaxel
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Somerville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 810 participants |
| Start Date | 2026-03-12 |
| Est. Completion | 2027-03-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07485166
The ClinicalTrials.gov registry entry for NCT07485166 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 810 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Advanced Non-squamous Non-small-cell Lung Cancer appearing as the primary indexed condition, and to 2 interventions - of which Initiation of nivolumab is the first listed.
NCT07485166 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07485166 about?
NCT07485166 is a clinical study titled "Emulation of the CheckMate 017/057 (NCT01642004 and NCT01673867) Trials Using Specialty Oncology Electronic Health Records Databases". Investigators are building an empirical evidence base for real world data through large-scale emulation of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how to implement such s...
What is the current status of trial NCT07485166?
This trial is currently active not recruiting. The enrollment target is 810 participants. The study started on 2026-03-12. Estimated completion is 2027-03-12.
What conditions does trial NCT07485166 study?
This clinical trial studies the following conditions: Advanced Non-squamous Non-small-cell Lung Cancer, Advanced Non-Small Cell Squamous Lung Cancer.
What interventions are being tested in trial NCT07485166?
The interventions under investigation include: Initiation of nivolumab (DRUG), Initiation of docetaxel (DRUG).
Who is sponsoring clinical trial NCT07485166?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07485166 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Advanced Non-squamous Non-small-cell Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification
RECRUITING · Phase 1
-
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
RECRUITING · Phase 2
Explore more on PlainTrial
Advanced Non-squamous Non-small-cell Lung Cancer
All registered trials for this condition
Advanced Non-Small Cell Squamous Lung Cancer
All registered trials for this condition
Massachusetts
All trials with a study site in Massachusetts
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.